Search Results for: Influenza

1761 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
CALM1 and RPL22 calmodulin 1 (phosphorylase kinase, delta) ribosomal protein L22
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALM1 and RPS4Y1 calmodulin 1 (phosphorylase kinase, delta) ribosomal protein S4, Y-linked 1
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALM1 and RPS8 calmodulin 1 (phosphorylase kinase, delta) ribosomal protein S8
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALM1 and RPS14 calmodulin 1 (phosphorylase kinase, delta) ribosomal protein S14
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALM1 and RPS15A calmodulin 1 (phosphorylase kinase, delta) ribosomal protein S15a
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALM1 and HSP90AA1 calmodulin 1 (phosphorylase kinase, delta) heat shock protein 90kDa alpha (cytosolic), class A member 1
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • HSF1 activation
  • Regulatory RNA pathways
  • Signaling by EGFRvIII in Cancer
  • Regulation of PLK1 Activity at G2/M Transition
  • Influenza Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Uptake and actions of bacterial toxins
  • EPH-Ephrin signaling
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Fcgamma receptor (FCGR) dependent phagocytosis
  • Recruitment of mitotic centrosome proteins and complexes
  • Regulation of actin dynamics for phagocytic cup formation
  • vRNP Assembly
  • Influenza Infection
  • Signaling by ERBB2
  • Signaling by VEGF
  • Signaling by EGFR in Cancer
  • Sema3A PAK dependent Axon repulsion
  • Mitotic G2-G2/M phases
  • Uptake and function of diphtheria toxin
  • PIWI-interacting RNA (piRNA) biogenesis
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Attenuation phase
  • G2/M Transition
  • VEGFA-VEGFR2 Pathway
  • HSF1-dependent transactivation
  • EPHA-mediated growth cone collapse
  • Metabolism of nitric oxide
  • VEGFR2 mediated vascular permeability
  • Loss of Nlp from mitotic centrosomes
  • Scavenging by Class F Receptors
  • eNOS activation and regulation
  • Innate Immune System
  • Semaphorin interactions
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • Assembly of the primary cilium
  • Cellular response to heat stress
  • Anchoring of the basal body to the plasma membrane
  • Cell Cycle, Mitotic
  • eNOS activation
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Centrosome maturation
  • Constitutive Signaling by EGFRvIII
  • Rifabutin
  • Nedocromil
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • Geldanamycin
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • 9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine
  • 4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid
  • 17-Dmag
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine
  • Adenosine-5\'-Diphosphate
  • 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
  • 4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole
  • 9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine
  • 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
  • 8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine
  • 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
  • N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE
  • 4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE
  • 5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE
  • 2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide
  • 4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL
  • (3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one
  • 6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE
  • 3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE
  • N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE
  • 5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE
  • 4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol
  • 4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL
  • 4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol
  • 8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE
  • 4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine
  • (5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime
  • 8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-
  • 4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol
  • 2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol
  • 2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide
  • 4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine
  • 4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine
  • 3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE
  • 2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE
CALM1 and RANBP2 calmodulin 1 (phosphorylase kinase, delta) RAN binding protein 2
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Mitotic Prometaphase
  • Separation of Sister Chromatids
  • Mitotic Prophase
  • HIV Infection
  • Nuclear import of Rev protein
  • Regulatory RNA pathways
  • Rev-mediated nuclear export of HIV RNA
  • Nuclear Envelope Breakdown
  • Mitotic Anaphase
  • SLC-mediated transmembrane transport
  • M Phase
  • Influenza Life Cycle
  • HIV Life Cycle
  • Influenza Viral RNA Transcription and Replication
  • Rev-mediated nuclear export of HIV RNA
  • Myoclonic epilepsy of Lafora
  • Glycogen storage diseases
  • Transcriptional regulation by small RNAs
  • Vpr-mediated nuclear import of PICs
  • ISG15 antiviral mechanism
  • Interferon Signaling
  • Host Interactions of HIV factors
  • Regulation of Glucokinase by Glucokinase Regulatory Protein
  • Nuclear Pore Complex (NPC) Disassembly
  • Cytokine Signaling in Immune system
  • Interactions of Vpr with host cellular proteins
  • Interactions of Rev with host cellular proteins
  • Influenza Infection
  • Hexose transport
  • Cell Cycle, Mitotic
  • Late Phase of HIV Life Cycle
  • Antiviral mechanism by IFN-stimulated genes
  • Resolution of Sister Chromatid Cohesion
  • Viral Messenger RNA Synthesis
  • Metabolism of carbohydrates
  • Glucose transport
  • Mitotic Metaphase and Anaphase
CALM1 and POLR2B calmodulin 1 (phosphorylase kinase, delta) polymerase (RNA) II (DNA directed) polypeptide B, 140kDa
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • RNA Polymerase II Promoter Escape
  • mRNA Splicing
  • Formation of HIV-1 elongation complex containing HIV-1 Tat
  • PIWI-interacting RNA (piRNA) biogenesis
  • Nucleotide Excision Repair
  • RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
  • RNA Polymerase II Transcription
  • Abortive elongation of HIV-1 transcript in the absence of Tat
  • HIV Infection
  • Regulatory RNA pathways
  • Formation of the Early Elongation Complex
  • Tat-mediated elongation of the HIV-1 transcript
  • Tat-mediated HIV elongation arrest and recovery
  • Formation of transcription-coupled NER (TC-NER) repair complex
  • RNA Pol II CTD phosphorylation and interaction with CE
  • RNA Polymerase II Pre-transcription Events
  • Dual incision reaction in TC-NER
  • Influenza Life Cycle
  • HIV elongation arrest and recovery
  • HIV Life Cycle
  • HIV Transcription Initiation
  • Influenza Viral RNA Transcription and Replication
  • RNA Pol II CTD phosphorylation and interaction with CE
  • Transcriptional regulation of pluripotent stem cells
  • RNA Polymerase II HIV Promoter Escape
  • HIV Transcription Elongation
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
  • Transcriptional regulation by small RNAs
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Capping
  • mRNA Splicing - Minor Pathway
  • mRNA Splicing - Major Pathway
  • MicroRNA (miRNA) biogenesis
  • Influenza Infection
  • Pausing and recovery of Tat-mediated HIV elongation
  • Late Phase of HIV Life Cycle
  • Formation of RNA Pol II elongation complex
  • RNA Polymerase II Transcription Initiation And Promoter Clearance
  • Pausing and recovery of HIV elongation
  • Formation of HIV elongation complex in the absence of HIV Tat
  • Transcription-coupled NER (TC-NER)
  • Viral Messenger RNA Synthesis
  • Formation of the HIV-1 Early Elongation Complex
  • RNA Polymerase II Transcription Initiation
  • Transcription of the HIV genome
  • RNA Polymerase II Transcription Elongation
CALM1 and RPL13A calmodulin 1 (phosphorylase kinase, delta) ribosomal protein L13a
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALM2 and RPSA calmodulin 2 (phosphorylase kinase, delta) ribosomal protein SA
  • Signaling by the B Cell Receptor (BCR)
  • Signaling by GPCR
  • Ca-dependent events
  • CaM pathway
  • Signaling by FGFR in disease
  • Phospholipase C-mediated cascade
  • Signaling by Wnt
  • Platelet degranulation
  • Signaling by EGFRvIII in Cancer
  • CREB phosphorylation through the activation of Ras
  • PLCG1 events in ERBB2 signaling
  • Glucose metabolism
  • DAP12 signaling
  • Synthesis of IP3 and IP4 in the cytosol
  • Myoclonic epilepsy of Lafora
  • Response to elevated platelet cytosolic Ca2+
  • Glycogen storage diseases
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • Activation of Ca-permeable Kainate Receptor
  • Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
  • Ionotropic activity of Kainate Receptors
  • Signaling by PDGF
  • Calmodulin induced events
  • CaMK IV-mediated phosphorylation of CREB
  • DAP12 interactions
  • Glycogen breakdown (glycogenolysis)
  • Opioid Signalling
  • Activation of Kainate Receptors upon glutamate binding
  • Diseases associated with visual transduction
  • Inositol phosphate metabolism
  • EGFR interacts with phospholipase C-gamma
  • CaMK IV-mediated phosphorylation of CREB
  • Signaling by ERBB2
  • Signaling by EGFR
  • Signaling by VEGF
  • CREB phosphorylation through the activation of CaMKK
  • Downstream signal transduction
  • Calmodulin induced events
  • CREB phosphorylation through the activation of CaMKII
  • Fc epsilon receptor (FCERI) signaling
  • Signaling by EGFR in Cancer
  • Transcriptional activation of mitochondrial biogenesis
  • Metabolism of carbohydrates
  • Platelet activation, signaling and aggregation
  • Adaptive Immune System
  • Transmission across Chemical Synapses
  • Ras activation uopn Ca2+ infux through NMDA receptor
  • Organelle biogenesis and maintenance
  • Cam-PDE 1 activation
  • Translocation of GLUT4 to the plasma membrane
  • VEGFA-VEGFR2 Pathway
  • DAG and IP3 signaling
  • CaM pathway
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Metabolism of nitric oxide
  • VEGFR2 mediated cell proliferation
  • VEGFR2 mediated vascular permeability
  • Activation of NMDA receptor upon glutamate binding and postsynaptic events
  • The phototransduction cascade
  • Downstream signaling of activated FGFR
  • DARPP-32 events
  • eNOS activation and regulation
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Innate Immune System
  • Post NMDA receptor activation events
  • Signalling by NGF
  • PLC beta mediated events
  • Smooth Muscle Contraction
  • Signaling by Ligand-Responsive EGFR Variants in Cancer
  • NGF signalling via TRKA from the plasma membrane
  • G-protein mediated events
  • Signaling by Overexpressed Wild-Type EGFR in Cancer
  • Mitochondrial biogenesis
  • beta-catenin independent WNT signaling
  • Signaling by FGFR
  • eNOS activation
  • Cam-PDE 1 activation
  • Ca2+ pathway
  • Visual phototransduction
  • Activation of CaMK IV
  • PLC-gamma1 signalling
  • FCERI mediated Ca+2 mobilization
  • Nonsense-Mediated Decay (NMD)
  • Translation initiation complex formation
  • Translation
  • SRP-dependent cotranslational protein targeting to membrane
  • Eukaryotic Translation Termination
  • Peptide chain elongation
  • Influenza Infection
  • Viral mRNA Translation
  • L13a-mediated translational silencing of Ceruloplasmin expression
  • Influenza Life Cycle
  • Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
  • Ribosomal scanning and start codon recognition
  • Formation of the ternary complex, and subsequently, the 43S complex
  • Influenza Viral RNA Transcription and Replication
  • GTP hydrolysis and joining of the 60S ribosomal subunit
  • Eukaryotic Translation Initiation
  • Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
  • Formation of a pool of free 40S subunits
  • Eukaryotic Translation Elongation
  • Cap-dependent Translation Initiation
  • Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
CALR and SUMO4 calreticulin small ubiquitin-like modifier 4
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
CALR and HLA-A calreticulin major histocompatibility complex, class I, A
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Interferon gamma signaling
  • Interferon Signaling
  • Endosomal/Vacuolar pathway
  • Cytokine Signaling in Immune system
  • Interferon alpha/beta signaling
  • Class I MHC mediated antigen processing & presentation
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Adaptive Immune System
  • Interferon gamma signaling
  • Interferon Signaling
  • Endosomal/Vacuolar pathway
  • Cytokine Signaling in Immune system
  • Interferon alpha/beta signaling
  • Class I MHC mediated antigen processing & presentation
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Adaptive Immune System
CALR and MBL2 calreticulin mannose-binding lectin (protein C) 2, soluble
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Creation of C4 and C2 activators
  • Complement cascade
  • Initial triggering of complement
  • Lectin pathway of complement activation
  • Innate Immune System
CALR and HLA-E calreticulin major histocompatibility complex, class I, E
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • DAP12 interactions
  • Interferon Signaling
  • Cytokine Signaling in Immune system
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Interferon gamma signaling
  • DAP12 signaling
  • Endosomal/Vacuolar pathway
  • Interferon alpha/beta signaling
  • Class I MHC mediated antigen processing & presentation
  • Antigen processing-Cross presentation
  • Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
  • ER-Phagosome pathway
  • Innate Immune System
  • Adaptive Immune System
CALR and TSHR calreticulin thyroid stimulating hormone receptor
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
  • Signaling by GPCR
  • GPCR downstream signaling
  • G alpha (s) signalling events
  • Class A/1 (Rhodopsin-like receptors)
  • Hormone ligand-binding receptors
  • Metabolic disorders of biological oxidation enzymes
  • GPCR ligand binding
  • Thyrotropin Alfa
CALR and ITGA2B calreticulin integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Signal transduction by L1
  • Axon guidance
  • p130Cas linkage to MAPK signaling for integrins
  • Integrin alphaIIb beta3 signaling
  • L1CAM interactions
  • Platelet degranulation
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • Platelet Aggregation (Plug Formation)
  • Response to elevated platelet cytosolic Ca2+
  • ECM proteoglycans
  • Integrin cell surface interactions
  • Platelet activation, signaling and aggregation
  • Abciximab
  • Tirofiban
CALR and ITGA3 calreticulin integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Laminin interactions
  • Integrin cell surface interactions
  • Basigin interactions
  • Cell surface interactions at the vascular wall
CALR and ITGAV calreticulin integrin, alpha V
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Signal transduction by L1
  • Axon guidance
  • Elastic fibre formation
  • L1CAM interactions
  • Non-integrin membrane-ECM interactions
  • VEGFA-VEGFR2 Pathway
  • Cell surface interactions at the vascular wall
  • PECAM1 interactions
  • Molecules associated with elastic fibres
  • Syndecan interactions
  • Laminin interactions
  • Signaling by VEGF
  • ECM proteoglycans
  • Integrin cell surface interactions
  • Class I MHC mediated antigen processing & presentation
  • Antigen processing-Cross presentation
  • Cross-presentation of particulate exogenous antigens (phagosomes)
  • Adaptive Immune System
CALR and F5 calreticulin coagulation factor V (proaccelerin, labile factor)
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Common Pathway
  • Response to elevated platelet cytosolic Ca2+
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • Formation of Fibrin Clot (Clotting Cascade)
  • Drotrecogin alfa
  • Phenylmercury
CALR and F8 calreticulin coagulation factor VIII, procoagulant component
  • Diseases of glycosylation
  • Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
  • Defective MGAT2 causes MGAT2-CDG (CDG-2a)
  • Defective ALG1 causes ALG1-CDG (CDG-1k)
  • Antigen Presentation: Folding, assembly and peptide loading of class I MHC
  • Virus Assembly and Release
  • Defective MOGS causes MOGS-CDG (CDG-2b)
  • Influenza Life Cycle
  • Defective ALG9 causes ALG9-CDG (CDG-1l)
  • Defective MAN1B1 causes MRT15
  • Scavenging by Class F Receptors
  • Class I MHC mediated antigen processing & presentation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle
  • Scavenging by Class A Receptors
  • Assembly of Viral Components at the Budding Site
  • ATF6-alpha activates chaperones
  • Unfolded Protein Response (UPR)
  • Defective ALG11 causes ALG11-CDG (CDG-1p)
  • Defective ALG2 causes ALG2-CDG (CDG-1i)
  • Post-translational protein modification
  • Defective ALG3 causes ALG3-CDG (CDG-1d)
  • Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
  • Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
  • ATF6-alpha activates chaperone genes
  • Influenza Infection
  • Defective RFT1 causes RFT1-CDG (CDG-1n)
  • Defective ALG6 causes ALG6-CDG (CDG-1c)
  • Asparagine N-linked glycosylation
  • Defective ALG8 causes ALG8-CDG (CDG-1h)
  • Defective MPDU1 causes MPDU1-CDG (CDG-1f)
  • Defective ALG12 causes ALG12-CDG (CDG-1g)
  • Antigen processing-Cross presentation
  • ER-Phagosome pathway
  • Diseases associated with N-glycosylation of proteins
  • Adaptive Immune System
  • Calnexin/calreticulin cycle
  • Common Pathway
  • Intrinsic Pathway
  • Response to elevated platelet cytosolic Ca2+
  • Platelet degranulation
  • Platelet activation, signaling and aggregation
  • Formation of Fibrin Clot (Clotting Cascade)
  • Drotrecogin alfa
  • Coagulation Factor IX

Page 14 out of 89 pages